Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
April 18, 2019

LabCorp to buy Envigo’s non-clinical research services business in $485m deal

LabCorp’s Covance Drug Development segment is set to acquire Envigo’s non-clinical research services business, while Envigo’s Research Models Services business will purchase the Covance Research Products business.

Image: LabCorp has agreed to acquire Envigo’s non-clinical research services business. Photo: courtesy of adamr / FreeDigitalPhotos.net.